Vaccines, Cellular Therapy, Neoantigen Targeting最新文献

筛选
英文 中文
Abstract IA23: Allele-specific HLA loss and immune escape in lung cancer evolution 摘要:肺癌进化过程中等位基因特异性HLA缺失和免疫逃逸
Vaccines, Cellular Therapy, Neoantigen Targeting Pub Date : 2018-09-01 DOI: 10.1158/1557-3265.aacriaslc18-ia23
N. Mcgranahan, R. Rosenthal, C. Hiley, A. Rowan, T. Watkins, G. Wilson, N. Birkbak, S. Veeriah, P. Loo, Javier Herrero, C. Swanton
{"title":"Abstract IA23: Allele-specific HLA loss and immune escape in lung cancer evolution","authors":"N. Mcgranahan, R. Rosenthal, C. Hiley, A. Rowan, T. Watkins, G. Wilson, N. Birkbak, S. Veeriah, P. Loo, Javier Herrero, C. Swanton","doi":"10.1158/1557-3265.aacriaslc18-ia23","DOIUrl":"https://doi.org/10.1158/1557-3265.aacriaslc18-ia23","url":null,"abstract":"","PeriodicalId":432619,"journal":{"name":"Vaccines, Cellular Therapy, Neoantigen Targeting","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133735590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract IA24: Are tumors predictable? Inherited immune variation constrains tumor evolution 摘要:肿瘤是可预测的吗?遗传免疫变异限制肿瘤进化
Vaccines, Cellular Therapy, Neoantigen Targeting Pub Date : 2018-09-01 DOI: 10.1158/1557-3265.AACRIASLC18-IA24
Rachel Marty, S. Kaabinejadian, David Rossel, M. Slifker, J. L. D. Haar, H. Engin, N. Prisco, T. Ideker, W. Hildebrand, Joan Font-Burgada, H. Carter
{"title":"Abstract IA24: Are tumors predictable? Inherited immune variation constrains tumor evolution","authors":"Rachel Marty, S. Kaabinejadian, David Rossel, M. Slifker, J. L. D. Haar, H. Engin, N. Prisco, T. Ideker, W. Hildebrand, Joan Font-Burgada, H. Carter","doi":"10.1158/1557-3265.AACRIASLC18-IA24","DOIUrl":"https://doi.org/10.1158/1557-3265.AACRIASLC18-IA24","url":null,"abstract":"Recent studies have characterized the extensive somatic alterations that arise during cancer, and various studies have probed rare inherited mutations that lead to early-onset cancer syndromes. However, little is understood about the role of genetic background in “sporadic” adulthood cancers. The somatic evolution of a tumor may be significantly affected by inherited polymorphisms carried in the germline. The region encoding the Major Histocompatibility Complex Class I (MHC-I) is one of the most variable regions in the human population. MHC-I is a molecule that exposes the intracellular protein content of a cell on the cell surface, allowing T cells to detect mutated or foreign peptides. Each individual carries six MHC-I alleles that define the set of peptides that can be effectively presented for immune surveillance. We hypothesized that individual variation in MHC-I could create personal gaps in immune surveillance, generating individual-specific susceptibility for cells to acquire specific oncogenic mutations. We tested this hypothesis through the development and application of a residue-centric patient presentation score to 1,018 recurrent oncogenic mutations in 9,176 cancer patients. This analysis found that cancer-causing mutations were more likely to be observed when a patient’s genotype-based scores suggested poor MHC-I based presentation of those mutations. Mutations that were poorly presented by most patients were also more likely to reach high frequency among tumors. Thus the landscape of oncogenic mutations observed in clinically diagnosed tumors is shaped by MHC-I genotype-restricted immunoediting during tumor formation, and individual MHC-I genotype provides information about the mutations likely to emerge in tumors that develop later in life. Citation Format: Rachel Marty, Saghar Kaabinejadian, David Rossel, Michael J. Slifker, Joris Van de Haar, Hattice Billur Engin, Nicola de Prisco, Trey Ideker, William H. Hildebrand, Joan Font-Burgada, Hannah Carter. Are tumors predictable? Inherited immune variation constrains tumor evolution [abstract]. In: Proceedings of the Fifth AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic; Jan 8-11, 2018; San Diego, CA. Philadelphia (PA): AACR; Clin Cancer Res 2018;24(17_Suppl):Abstract nr IA24.","PeriodicalId":432619,"journal":{"name":"Vaccines, Cellular Therapy, Neoantigen Targeting","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127555199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信